You are here


Company Information
245 MAIN ST FL 2
CAMBRIDGE, MA 02142-1064
United States



# of Employees: 7

Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts

Award Listing

  1. Evaluation of USP30 small molecule inhibitors in models relevant to Cardiac Aging

    Amount: $299,497.00

    ABSTRACT Vincere Biosciences has proprietary USP30 inhibitor small molecules being optimized in vivo towards development candidates for heart failure (HF) and cardiac aging. HF is an age-related disor ...

    SBIRPhase I2022Department of Health and Human Services National Institutes of Health
  2. Discovery and Development of USP30 inhibitors as Disease-Modifying Therapy for Parkinson's disease.

    Amount: $251,987.00

    PROJECT SUMMARY/ABSTRACTThe proposed Phase I research is designed to establish the technical/scientific merit and feasibility of developing first/best-in-class, USP30 inhibitors for the treatment of P ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government